Natalizumab in Inclusion Body Myositis (IBM)

Clinical trial NCT02483845 · UNKNOWN

Trial details

NCT number: NCT02483845
Sponsor: Phoenix Neurological Associates, LTD
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Inclusion Body Myositis (IBM)

Start date: 2013-05-01
Primary completion: 2017-11-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.